FDx Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $206K | Sell |
1,481
-843
| -36% | -$118K | 0.07% | 178 |
|
|
2025
Q4 | $285K | Buy |
2,324
+52
| +2% | +$6.32K | 0.15% | 70 |
|
|
2025
Q3 | $272K | Sell |
2,272
-319
| -12% | -$36.3K | 0.08% | 142 |
|
|
2025
Q2 | $287K | Sell |
2,591
-507
| -16% | -$54K | 0.09% | 135 |
|
|
2025
Q1 | $347K | Sell |
3,098
-1,328
| -30% | -$137K | 0.11% | 112 |
|
|
2024
Q4 | $409K | Sell |
4,426
-939
| -18% | -$84.5K | 0.12% | 112 |
|
|
2024
Q3 | $450K | Buy |
5,365
+117
| +2% | +$8.93K | 0.12% | 113 |
|
|
2024
Q2 | $360K | Sell |
5,248
-591
| -10% | -$39.4K | 0.1% | 126 |
|
|
2024
Q1 | $428K | Sell |
5,839
-310
| -5% | -$23.8K | 0.07% | 226 |
|
|
2023
Q4 | $498K | Buy |
6,149
+1,741
| +39% | +$135K | 0.04% | 393 |
|
|
2023
Q3 | $330K | Sell |
4,408
-1,151
| -21% | -$88.5K | 0.03% | 446 |
|
|
2023
Q2 | $428K | Sell |
5,559
-7,180
| -56% | -$573K | 0.02% | 493 |
|
|
2023
Q1 | $1.09M | Hold |
12,739
| – | – | 0.05% | 278 |
|
|
2022
Q4 | $1.09M | Sell |
12,739
-4,297
| -25% | -$340K | 0.05% | 278 |
|
|
2022
Q3 | $1.05M | Sell |
17,036
-2,053
| -11% | -$129K | 0.05% | 272 |
|
|
2022
Q2 | $1.18M | Buy |
19,089
+2,867
| +18% | +$178K | 0.04% | 290 |
|
|
2022
Q1 | $964K | Buy |
16,222
+291
| +2% | +$18.6K | 0.03% | 334 |
|
|
2021
Q4 | $1.16M | Sell |
15,931
-893
| -5% | -$61.5K | 0.03% | 333 |
|
|
2021
Q3 | $1.18M | Sell |
16,824
-149
| -0.9% | -$10.5K | 0.04% | 311 |
|
|
2021
Q2 | $1.17M | Sell |
16,973
-1,749
| -9% | -$117K | 0.04% | 302 |
|
|
2021
Q1 | $1.21M | Buy |
18,722
+2,366
| +14% | +$153K | 0.05% | 253 |
|
|
2020
Q4 | $953K | Buy |
16,356
+3,595
| +28% | +$217K | 0.04% | 281 |
|
|
2020
Q3 | $806K | Sell |
12,761
-11,739
| -48% | -$814K | 0.04% | 270 |
|
|
2020
Q2 | $1.89M | Buy |
24,500
+8,296
| +51% | +$636K | 0.1% | 151 |
|
|
2020
Q1 | $1.21M | Buy |
16,204
+1,845
| +13% | +$127K | 0.08% | 179 |
|
|
2019
Q4 | $933K | Sell |
14,359
-3,271
| -19% | -$213K | 0.05% | 232 |
|
|
2019
Q3 | $1.12M | Buy |
17,630
+11,697
| +197% | +$765K | 0.08% | 201 |
|
|
2019
Q2 | $401K | Sell |
5,933
-281
| -5% | -$18.5K | 0.02% | 538 |
|
|
2019
Q1 | $404K | Sell |
6,214
-266
| -4% | -$17.7K | 0.02% | 503 |
|
|
2018
Q4 | $405K | Sell |
6,480
-12,330
| -66% | -$862K | 0.03% | 343 |
|
|
2018
Q3 | $1.45M | Buy |
18,810
+667
| +4% | +$50.4K | 0.05% | 268 |
|
|
2018
Q2 | $1.28M | Sell |
18,143
-28,632
| -61% | -$2.02M | 0.05% | 318 |
|
|
2018
Q1 | $3.53M | Buy |
46,775
+1,469
| +3% | +$117K | 0.11% | 160 |
|
|
2017
Q4 | $3.25M | Buy |
45,306
+7,431
| +20% | +$564K | 0.09% | 197 |
|
|
2017
Q3 | $3.07M | Buy |
37,875
+5,354
| +16% | +$409K | 0.08% | 205 |
|
|
2017
Q2 | $2.3M | Sell |
32,521
-8,399
| -21% | -$559K | 0.07% | 256 |
|
|
2017
Q1 | $2.78M | Sell |
40,920
-18,676
| -31% | -$1.31M | 0.09% | 221 |
|
|
2016
Q4 | $4.27M | Buy |
59,596
+18,628
| +45% | +$1.38M | 0.12% | 152 |
|
|
2016
Q3 | $3.24M | Buy |
40,968
+4,555
| +13% | +$370K | 0.13% | 130 |
|
|
2016
Q2 | $3.04M | Sell |
36,413
-7,141
| -16% | -$634K | 0.14% | 129 |
|
|
2016
Q1 | $4M | Buy |
43,554
+3,988
| +10% | +$360K | 0.18% | 99 |
|
|
2015
Q4 | $4M | Buy |
39,566
+5,287
| +15% | +$550K | 0.18% | 102 |
|
|
2015
Q3 | $3.37M | Sell |
34,279
-15,465
| -31% | -$1.72M | 0.29% | 64 |
|
|
2015
Q2 | $5.82M | Sell |
49,744
-14,656
| -23% | -$1.6M | 0.29% | 67 |
|
|
2015
Q1 | $6.32M | Buy |
64,400
+43
| +0.1% | +$4.37K | 0.14% | 136 |
|
|
2014
Q4 | $6.07M | Sell |
64,357
-3,601
| -5% | -$372K | 0.37% | 42 |
|
|
2014
Q3 | $7.23M | Buy |
67,958
+6,005
| +10% | +$588K | 0.47% | 28 |
|
|
2014
Q2 | $5.14M | Buy |
61,953
+10,405
| +20% | +$810K | 0.34% | 48 |
|
|
2014
Q1 | $3.65M | Buy |
51,548
+16,456
| +47% | +$1.29M | 0.3% | 60 |
|
|
2013
Q4 | $2.64M | Buy |
35,092
+6,019
| +21% | +$419K | 0.26% | 86 |
|
|
2013
Q3 | $1.83M | Sell |
29,073
-998
| -3% | -$59.6K | 0.22% | 101 |
|
|
2013
Q2 | $1.54M | Buy |
+30,071
| New | +$1.57M | 0.2% | 112 |
|
Other funds holding GILD
VCM
VPM
FDx Advisors's GILD Position: Q1 2026 in Review
FDx Advisors reduced its Gilead Sciences (GILD) stake by 36% in Q1 2026, selling an estimated $118K and leaving 1,481 shares worth $206K. The position accounts for 0.07% of the portfolio, ranked #178.
FDx Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.23M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- FDx Advisors held 1,481 shares of Gilead Sciences worth $206K as of Q1 2026.
- FDx Advisors sold 843 Gilead Sciences shares in Q1 2026, an estimated $118K.
- Gilead Sciences made up 0.07% of FDx Advisors's portfolio in Q1 2026, its #178 holding.
- FDx Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- FDx Advisors's Gilead Sciences position peaked at $7.23M in Q3 2014.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on FDx Advisors's 13F filing for Q1 2026, filed 1 May 2026.